Erica L. Lowthers SIM. IP Practice
Results 1 to 4 of 4
Canada - June 7 2013
Bayer attempted to broaden the scope of a product-by-process claim by arguing that the process recited in the claim was a non-essential feature and…
Canada - February 22 2013
A broad construction of the term “pain” to include all types of pain and an inventor’s admission that pregabalin (LyricaTM) does not block acute pain…
Canada - June 13 2012
This decision deals with the Patent Appeal Board's ("PAB") review of the final rejection of Canadian Patent Application No. 2,308,623 (the “`623 Application”), to the New York Blood Center, Inc., directed to methods of making antibodies and hybridoma cells that produce antibodies.
Canada - April 27 2012
This decision deals with the Patent Appeal Board’s (“PAB”) review of the final rejection of Canadian Patent Application No. 2,268,812 (“`812 Application”), directed to methods for producing transgenic animal models for Alzheimer’s Disease (“AD”).